Johnson & Johnson's $13.1 Billion Shockwave Medical Acquisition Strengthens MedTech Business
TL;DR
Johnson & Johnson has agreed to acquire Shockwave Medical for $12.5 billion, expanding its portfolio of medical devices for treating heart diseases. The deal gives J&J access to Shockwave's catheter-based treatment using shockwaves to break down calcified plaque in heart vessels, complementing its focus on building its cardiac health business. This acquisition follows J&J's previous purchases in the heart device sector and is expected to close by mid-2024, financed through a combination of cash and debt.
Topics:businessbusinesshealthcare#acquisition#businesshealthcare#heart-diseases#johnson-and-johnson#medical-devices#shockwave-medical
- Johnson & Johnson boosts heart device business with $12.5 billion Shockwave Medical deal CNBC
- J&J to pump another $13B into its MedTech business with Shockwave deal ABC News
- J&J to buy Shockwave Medical in $13.1 billion acquisition USA TODAY
- J&J boosts heart device business with $12.5 bln Shockwave Medical deal Reuters
- Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion Investor's Business Daily
Want the full story? Read the original reporting
Read on CNBC